Immunostaining revealed a higher abundance of COX-2-positive cells in the lungs of the intermittent smoking-exposed group than in those of the non-smoking group, with a greater prevalence in lung adenomas (Figure 2H) than in lung adenocarcinomas (Figure 2I). Here, PTGS2 is linked to lung adenocarcinoma.